Karp Capital Management Corp Has $1.58 Million Stake in Thermo Fisher Scientific Inc (TMO)
Karp Capital Management Corp cut its holdings in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 97.0% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 9,071 shares of the medical research company’s stock after selling 290,463 shares during the period. Karp Capital Management Corp’s holdings in Thermo Fisher Scientific were worth $1,583,000 as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in TMO. BB&T Securities LLC raised its holdings in Thermo Fisher Scientific by 4.4% in the 1st quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock worth $13,798,000 after purchasing an additional 3,819 shares during the period. State Board of Administration of Florida Retirement System grew its holdings in Thermo Fisher Scientific by 0.9% in the second quarter. State Board of Administration of Florida Retirement System now owns 580,712 shares of the medical research company’s stock valued at $101,317,000 after purchasing an additional 5,213 shares during the period. Mitchell Capital Management Co. grew its holdings in Thermo Fisher Scientific by 40.3% in the second quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock valued at $7,841,000 after purchasing an additional 12,910 shares during the period. Toronto Dominion Bank grew its holdings in Thermo Fisher Scientific by 53.5% in the first quarter. Toronto Dominion Bank now owns 107,099 shares of the medical research company’s stock valued at $16,450,000 after purchasing an additional 37,307 shares during the period. Finally, IBM Retirement Fund grew its holdings in Thermo Fisher Scientific by 117.7% in the second quarter. IBM Retirement Fund now owns 9,537 shares of the medical research company’s stock valued at $1,860,000 after purchasing an additional 5,157 shares during the period. Hedge funds and other institutional investors own 83.36% of the company’s stock.
A number of research firms have recently commented on TMO. Cowen and Company restated an “outperform” rating and issued a $220.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. Goldman Sachs Group, Inc. (The) initiated coverage on Thermo Fisher Scientific in a research report on Tuesday, September 26th. They set a “buy” rating and a $225.00 target price on the stock. Zacks Investment Research cut shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Tuesday, September 12th. Citigroup Inc. reissued a “buy” rating and issued a $201.00 price target (up previously from $182.00) on shares of Thermo Fisher Scientific in a report on Monday, July 10th. Finally, BidaskClub raised shares of Thermo Fisher Scientific from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 11th. One equities research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $202.21.
In other news, Director Jim P. Manzi sold 1,000 shares of the stock in a transaction that occurred on Thursday, August 17th. The shares were sold at an average price of $175.20, for a total value of $175,200.00. Following the sale, the director now directly owns 38,757 shares in the company, valued at $6,790,226.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Peter E. Hornstra sold 3,894 shares of the stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total transaction of $721,090.92. Following the completion of the sale, the vice president now owns 19,751 shares in the company, valued at $3,657,490.18. The disclosure for this sale can be found here. Insiders have sold a total of 52,738 shares of company stock valued at $9,302,112 over the last 90 days. 0.49% of the stock is currently owned by insiders.
Thermo Fisher Scientific Inc (NYSE:TMO) opened at 191.54 on Tuesday. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $194.30. The stock has a market capitalization of $74.72 billion, a price-to-earnings ratio of 33.37 and a beta of 1.05. The firm has a 50-day moving average of $184.55 and a 200-day moving average of $173.10.
Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.92 billion. During the same quarter in the previous year, the company posted $2.03 EPS. The business’s revenue was up 10.2% on a year-over-year basis. Equities research analysts anticipate that Thermo Fisher Scientific Inc will post $9.34 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a dividend of $0.15 per share. The ex-dividend date is Thursday, September 14th. This represents a $0.60 annualized dividend and a yield of 0.31%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 10.45%.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.watchlistnews.com/karp-capital-management-corp-has-1-58-million-stake-in-thermo-fisher-scientific-inc-tmo/1604510.html.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.